BHEKISISA | Inequality didn’t rise from hell, it’s man-made — and there’s nothing like a pandemic to expose it

If you were a South African health journalist, like me, during the late 1990s and early 2000s, you were mostly an HIV/Aids reporter. Eight out of 10 stories you produced would have been about the epidemic. 

It was a time of unprecedented Aids-related deaths, government policy based on politics rather than science and activism that, in many respects, was as fierce as the fight against apartheid. 

I was a cub reporter, with limited insight, for the public broadcaster then, but following HIV/Aids during a controversial time when the government refused to provide lifesaving antiretroviral drugs to people infected with the virus quickly taught me an important thing: a pandemic isn’t simply a disease gone viral.

It’s a political, social, economic and human rights crisis because the germ which caused the outbreak travels through a society ravaged by inequality.

There’s nothing like a pandemic to expose what’s working and what’s not. Disease outbreaks are like magnifying glasses, they amplify everything — and our responses to such events are recorded. 

HIV/Aids and our more recent pandemic, Covid-19, for example, laid bare that inequality didn’t just appear from some hidden realm. It’s man-made. As the head of UNAids Winnie Byanyima aptly put it in a recent webinar: “Inequalities are a policy choice. They are choices our governments make.” 

Inequality, shows research, is one of the main reasons we still see Aids-related deaths in an era where we have all the antiretrovirals, HIV prevention pills, vaginal rings, injections and harm-reduction plans we need to end the pandemic. 

It was also one of the chief causes of so many unnecessary Covid-19 deaths. 

Why? Because inequalities, which we’ve normalised — such as women having less power than men, prejudice against gay and transgender people, making sex workers and drug users feel they’re not human enough to be served at clinics — frequently make it impossible to get lifesaving medicine to those who need it the most.  

Getting scientists to develop medicine that cures an illness, prevents it or turns it into a chronic disease that can be managed with medication is, therefore, a relatively small part of the solution. The more difficult thing is to get the pills, injections, vaccines, whatever it may be, to people who need them — and to then use it.

ARVs work but that doesn’t mean they get to everyone who needs them 

HIV and Covid-19 have shown us that just because there are pills or measures that science has proven can save lives, doesn’t mean people will necessarily take up the offer — people’s views on life, and their trust in the providers of such medication, influence their decisions. 

During Covid-19, for instance, whether someone was vaccinated or masked up had a lot to do with their political ideologies or religions. A 2021 study conducted by The Economist revealed the single biggest indicator of whether Americans would get vaccinated was who they voted for during the 2020 elections: supporters of the Republican Party’s former US president Donald Trump were 18 percentage points more likely to shun Covid vaccines than those who voted for the Democratic Party’s Joe Biden.  

In South Africa, home to an estimated 7.9-million people with HIV, 94% of infected people have been diagnosed, but of those who know they’ve contracted the virus, only 77% are on  treatment, health minister Joe Phaahla announced at last week’s South African Aids conference in Durban.  

Despite studies that show antiretroviral treatment (ART), if started in time, can increase an HIV-positive person’s life expectancy to almost the same age as that of uninfected people, 23% of diagnosed people in our country have chosen not to be on treatment.   

For many untreated people, this is, however, not a deliberate choice; society or their living conditions made the choice for them. 

Francois Venter, an infectious disease specialist and head of the health organisation  Ezintsha, points out: “We have testing available, and I think most people understand treatment is free and readily available and safe and effective. But things like denial, stigma, unfriendly services and simply the hassle factor for people with busy and full lives may all be contributing.” 

Making people feel bad about themselves at clinics stops them going there 

Take stigma, for example. When researchers from Ritshidze, a group of organisations that represent people with HIV, asked transgender people, men who have sex with men, sex workers and injecting drug users in South Africa about how they’re treated at government clinics, less than half, and in some cases not even a quarter, of the more than 9,000 respondents reported being greeted by a friendly face. In some of these groups, about one in five people said they’ve been blocked from getting health services.

People from these groups, known as key populations, have a higher chance of getting HIV than the general population, but knowing that they will be discriminated against, they stop going to clinics altogether, James Oladipo, one of the Ritshidze report’s authors, told Bhekisisa in May.

To address this, the health department is providing training to health workers to help them better understand transgender people, sex workers and men who have sex with men so they stop discriminating against those groups, said the department’s acting head of HIV Thato Chidarikire.

“This training has video clips [where real people share their] experiences. [For example] there’s a chapter on transgender people, with a trans person talking about their experience at a [health] facility. [The curriculum] starts from the basics, from [people’s] reality. What we’re trying to [achieve is] to say, 'Be sensitive, be competent'.”  

Medicine is social justice work in a world riven by inequity

Solving inequality, said Byanyima, requires formal agreed-upon rules in the form of policies because we can’t control people or governments’ day-to-day decisions without it.   

Because epidemics play out within societies with politics and economic and social orders, the answer to putting a stop to outbreaks that thrive in the midst of inequality lies in creating policies to get these sectors to work together, rather than merely making available medication at hospitals and clinics.

The late American medical anthropologist and physician Paul Farmer, who spent a large part of his career bringing high-quality services to poorer countries such as Haiti by fighting inequality, explained it well in an interview with the Boston Globe in 2008: “Medicine should be viewed as social justice work in a world that is so sick and riven by inequities.”  

What do policy solutions to inequality look like? 

We can learn a lot from the partnerships organisations in South Africa formed during our fight for access to HIV treatment, said Byanyima, to get the government to change its policy of not providing antiretroviral treatment in the late 1990s and early 2000s when lawyers, scientists, doctors, economists, human rights activists, journalists and communities of people living with HIV joined hands to stand up to the state.

As a result, about four years into the battle, in 2002, the Constitutional Court ordered then minister of health Manto Tshabalala-Msimang to provide HIV-positive pregnant women with antiretroviral drugs that could prevent them from infecting their babies, and in 2004 HIV treatment was expanded to the broader public.  

As a direct consequence of that court decision, and the pressure it put on the government to make free HIV treatment available widely, the annual death rate among black Africans, who make up the largest part of South Africa’s HIV cases, has decreased by 31% between 2006 and 2016 and the likelihood of someone reporting bad health is down by almost half.

In this case too, inequality has navigated the virus’ spread: studies have found that racist apartheid policies of “residential segregation”, of which the aftermath still restricts this demographic group’s access to health facilities, have strongly influenced this group’s high infection rate.   

Uganda’s ‘draconian’ anti-gay laws will make HIV spread faster

But South Africa’s fight against inequality should extend across its borders, said the South African National Aids Control Council’s Steve Letsike.

“Why are we [the government] bystanders when countries such as Uganda, Ghana, Kenya, Tanzania and Namibia introduce anti-homosexuality laws that seek to erase LGBTIQ+ people?” she asked at the Aids conference.

“It undermines the health agenda. Injustice there means injustice where we are.” 

In May, Ugandan resident Yoweri Museveni signed the country’s anti-homosexuality bill into law. The act extends the possible punishment for certain types of gay sex from life imprisonment to the death penalty. The new law also creates new crimes such as the “promotion of homosexuality” and increases the prison sentence for “attempted same-sex” sexual relations to 10 years. 

“This act is truly draconian and will lead to even more hate crimes and human rights violations against people who identify as LGBTIQ+ in a country where homophobia and transphobia is already rampant,” Letsike warned.  

This legislation will, undoubtedly, also lead to fewer LGBTIQ+ people accessing HIV services, and many new infections.  

Research in 10 sub-Saharan African countries found gay and other men who have sex with men who lived in countries which criminalised same-sex sexual activities were twice as likely to be infected with HIV compared to countries where it was legal. This increased to eight times more likely in countries with “severely criminalised” environments such as Uganda.  

One of the main reasons for this group’s higher likelihood to be HIV positive in countries with anti-gay laws is that it makes it difficult for people with same-sex relations to visit health facilities to get tested or treated for HIV as they fear arrest if their sexuality is discovered by health workers. 

Byanyima, whose home country is Uganda, said the missing ingredient to fight inequality is the political will of countries to make “tough choices to invest in people to end Aids”.

Policies should be based on evidence of what works, not morals

Political will and a tendency to allow prejudice and morals trump science. 

For example, despite HIV treatment and prevention pills that can reduce someone’s chances of getting HIV through sex by 99%, Aids is still the leading cause of death among women in Africa (after maternal mortality), said UNAids. Yet many teen girls, who are about three times as likely to become infected as teen boys, live in countries where they’re not allowed to get tested for HIV, or to obtain contraception, on their own — they can only do so with parental consent. 

Such “moralistic” laws, which are often intended to stop teens from having sex, frequently achieve the opposite. Research shows  in African countries where the age of consent for HIV testing is 15 years or lower, teens are 74% more likely to have been tested for HIV in the last year than in countries where the age of consent is 16 years or higher. 

The policy choices governments make, and the values they use to make them, will determine how fast — or slow — we end inequality and the pandemics inequality fuels.  

How inclusive we’re prepared to be in the end will frame our future. 

We need to constantly remind ourselves of an important question that Farmer often asked: “If access to healthcare is a human right, who is human enough to receive it?”